Atlas Trials

RWS of Inetetamab HER2 Positive Advanced Breast Cancer

Clinical trial NCT04963608 · UNKNOWN

Trial details

NCT number
NCT04963608
Sponsor
Zhiyong Yu
Status
UNKNOWN
Study type
OBSERVATIONAL
HER2-positive Advanced Breast Cancer
Start date
2021-07-01
Primary completion
2021-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.